Frec Markets’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Frec Markets's NVO Position: Q3 2026 in Review
Frec Markets reduced its Novo Nordisk (NVO) stake by 6.4% in Q3 2026, selling an estimated $30.7K and leaving 9,679 shares worth $367K. The position accounts for 0.02% of the portfolio, ranked #772.
Frec Markets first reported a position in NVO in Q4 2025 and has held it in 4 quarters since. The position peaked at $496K in Q2 2026. 1,220 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Frec Markets held 9,679 shares of Novo Nordisk worth $367K as of Q3 2026.
- Frec Markets sold 666 Novo Nordisk shares in Q3 2026, an estimated $30.7K.
- Novo Nordisk made up 0.02% of Frec Markets's portfolio in Q3 2026, its #772 holding.
- Frec Markets first reported a position in Novo Nordisk in Q4 2025 and has held it in 4 quarters since.
- Frec Markets's Novo Nordisk position peaked at $496K in Q2 2026.
- 1,220 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.